Drug:
Reaction: PRURITUS
20260101 - 20261231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 26542019 |
CA |
25 | 1 |
Intestinal resection, Pruritus, Hepatic enzyme increased, Anxiety, Cholelithiasis, Hepatic steatosis, Scar, |
||||
RISANKIZUMAB-RZAA, |
||||
| 402 | 26542069 |
US |
1 | |
Rash, Pruritus, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 403 | 26542145 |
US |
||
Pruritus, Flushing, |
||||
IRON DEXTRAN, |
||||
| 404 | 26542196 |
CA |
73 | |
Condition aggravated, Cough, Rhinorrhoea, Heart rate increased, Feeling cold, Pruritus, Fatigue, Arthralgia, Hypertension, Off label use, Intentional product use issue, Off label use, Intentional product use issue, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, BUDESONIDE, |
||||
| 405 | 26542216 |
US |
||
Pruritus, |
||||
BEMPEDOIC ACID AND EZETIMIBE, |
||||
| 406 | 26542242 |
US |
||
Pruritus, |
||||
BEMPEDOIC ACID AND EZETIMIBE, |
||||
| 407 | 26542252 |
US |
56 | 2 |
Pruritus, |
||||
BEMPEDOIC ACID AND EZETIMIBE, |
||||
| 408 | 26542261 |
US |
2 | |
Pruritus, Rhinorrhoea, Lacrimation increased, |
||||
BEMPEDOIC ACID AND EZETIMIBE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ROSUVASTATIN, CITALOPRAM, CITALOPRAM HYDROBROMIDE, |
||||
| 409 | 26542295 |
CA |
38 | |
Abdominal distension, Abdominal tenderness, Chest discomfort, Disturbance in attention, Dry skin, Dry throat, Dysphonia, Gastroenteritis viral, Hypertension, Lymph node palpable, Musculoskeletal pain, Nasal discharge discolouration, Oral pain, Oropharyngeal pain, Restless legs syndrome, Sinus pain, Skin exfoliation, Swelling, Erythema, Fatigue, Injection site swelling, Lymphadenopathy, Myalgia, Pruritus, Upper respiratory tract infection, Urticaria, Drug hypersensitivity, Drug ineffective, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, PENICILLIN G SODIUM, DIPHENHYDRAMINE HYDROCHLORIDE, LORATADINE, LORATADINE TABLET, MONTELUKAST SODIUM, |
||||
| 410 | 26542313 |
US |
||
Pruritus, Product dose omission issue, |
||||
CETIRIZINE HYDROCHLORIDE, |
||||
| 411 | 26542456 |
US |
33 | 1 |
Pruritus, Erythema, |
||||
BEMPEDOIC ACID, |
||||
| 412 | 26542458 |
US |
60 | 2 |
Pruritus, |
||||
BEMPEDOIC ACID, |
||||
| 413 | 26542473 |
US |
67 | 2 |
Pruritus, Peripheral swelling, |
||||
BEMPEDOIC ACID, |
||||
| 414 | 26542481 |
US |
||
Pruritus, Urticaria, |
||||
BEMPEDOIC ACID, |
||||
| 415 | 26542628 |
BR |
65 | 1 |
Colorectal cancer metastatic, Pneumonia, Thrombosis, Ocular hyperaemia, Erythema, Skin lesion, Lacrimation increased, Rash, Pruritus, Stomatitis, Rash pustular, Oral disorder, Eye swelling, Off label use, Asthenia, Skin swelling, Oral disorder, |
||||
PANITUMUMAB, PANITUMUMAB, PANITUMUMAB, PANITUMUMAB, PANITUMUMAB, EDOXABAN TOSYLATE, ATENOLOL, LEUCOVORIN CALCIUM, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, AMLODIPINE BESYLATE, DAPAGLIFLOZIN, DAPAGLIFLOZIN, |
||||
| 416 | 26542703 |
US |
||
Flushing, Oropharyngeal pain, Pruritus, Headache, Chest pain, Abdominal pain upper, |
||||
FERRIC DERISOMALTOSE, |
||||
| 417 | 26542865 |
EU |
66 | 2 |
Toxic skin eruption, Pruritus, |
||||
EZETIMIBE, |
||||
| 418 | 26542983 |
US |
65 | 1 |
Rash morbilliform, Erythema, Dry skin, Skin exfoliation, Pruritus, |
||||
DEPEMOKIMAB, MEPOLIZUMAB, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, PREDNISONE, PREDNISONE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, CEFUROXIME, AMOXICILLIN, AZATHIOPRINE, LINACLOTIDE, ROSUVASTATIN, FUROSEMIDE, PANTOPRAZOLE, VALSARTAN, VALSARTAN ORAL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, TIRZEPATIDE, ALBUTEROL SULFATE, |
||||
| 419 | 26542989 |
US |
2 | |
Pruritus, Peripheral swelling, |
||||
MEPOLIZUMAB, |
||||
| 420 | 26543016 |
CN |
83 | 1 |
Malaise, Pruritus, |
||||
IOHEXOL, |
||||
| 421 | 26543188 |
US |
||
Alopecia, Application site reaction, Chronic spontaneous urticaria, Depression, Dyspnoea, Haemorrhage, Headache, Hepatic enzyme increased, Tachycardia, Insomnia, Intervertebral disc protrusion, Malaise, Paraesthesia, Primary biliary cholangitis, Pruritus, Scratch, Skin burning sensation, Skin lesion, Skin plaque, Spinal meningeal cyst, Stress, Erythema, Product dose omission issue, Drug ineffective, Incorrect dose administered, Inappropriate schedule of product administration, Wrong technique in product usage process, |
||||
OMALIZUMAB, |
||||
| 422 | 26543230 |
US |
1 | |
Pruritus, |
||||
OMALIZUMAB, |
||||
| 423 | 26543412 |
US |
2 | |
Pruritus, |
||||
OXYBUTYNIN, |
||||
| 424 | 26543516 |
EU |
71 | 2 |
Neutropenia, Dermatitis bullous, Asthenia, Pruritus, Dysphagia, Nausea, Decreased appetite, Hypertransaminasaemia, Hypercreatininaemia, Somnolence, |
||||
RUCAPARIB, |
||||
| 425 | 26543527 |
CA |
36 | |
Cardiac disorder, Drug hypersensitivity, Ejection fraction decreased, Cardiac dysfunction, Diarrhoea, Fatigue, Dizziness, Hypersensitivity, Hypotension, Rash, Pruritus, |
||||
TRASTUZUMAB, PERTUZUMAB, BISOPROLOL FUMARATE, CANDESARTAN, PEGFILGRASTIM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 426 | 26543552 |
US |
||
Erythema, Pruritus, |
||||
ROSUVASTATIN, PREGABALIN, LEVOTHYROXINE SODIUM, ESCITALOPRAM, ACYCLOVIR, PANTOPRAZOLE SODIUM, |
||||
| 427 | 26543575 |
US |
41 | 2 |
Abdominal pain upper, Nausea, Diarrhoea, Fatigue, Pruritus, Drug ineffective, |
||||
SPESOLIMAB-SBZO, SPESOLIMAB, |
||||
| 428 | 26543576 |
US |
1 | |
Swelling, Pruritus, |
||||
BENAZEPRIL HYDROCHLORIDE, LEUPROLIDE ACETATE, AMLODIPINE, |
||||
| 429 | 26543582 |
US |
2 | |
Pruritus, Rash, Dermatitis contact, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 430 | 26543648 |
US |
42 | 2 |
Pruritus, |
||||
SEBETRALSTAT, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, FAMOTIDINE, HYDROXYCHLOROQUINE SULFATE, |
||||
| 431 | 26543787 |
US |
56 | 2 |
Pruritus, |
||||
TRALOKINUMAB-LDRM, |
||||
| 432 | 26543842 |
JP |
84 | 2 |
Cardiac failure, Face oedema, Product prescribing issue, Pruritus, Drug ineffective, Erythema, Extra dose administered, Somnolence, Malaise, |
||||
IVERMECTIN, |
||||
| 433 | 26543843 |
CN |
54 | 2 |
Gastrooesophageal reflux disease, Abdominal pain upper, Pruritus, Muscular weakness, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 434 | 26543940 |
US |
1 | |
Off label use, Pruritus, Skin burning sensation, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 435 | 26543975 |
42 | ||
Rash erythematous, Pruritus, Burning sensation, Product use in unapproved indication, |
||||
BIMEKIZUMAB, |
||||
| 436 | 26544145 |
US |
55 | 2 |
Blister, Pruritus, |
||||
TRALOKINUMAB-LDRM, |
||||
| 437 | 26544186 |
|||
Pain, Pruritus, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 438 | 26544222 |
CN |
44 | 1 |
Drug hypersensitivity, Rash, Pruritus, Erythema, |
||||
NIFEDIPINE, |
||||
| 439 | 26544259 |
GB |
||
Posterior reversible encephalopathy syndrome, Acute kidney injury, Rash, Pruritus, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), ANASTROZOLE, ANASTROZOLE TABLETS, DENOSUMAB, |
||||
| 440 | 26544357 |
56 | 2 | |
Product leakage, Infusion site erythema, Infusion site discolouration, Infusion site swelling, Infusion site pain, Headache, Pruritus, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, AZELASTINE, |
||||
| 441 | 26544674 |
82 | ||
Back pain, Blood pressure increased, Papule, Heart rate increased, Pruritus, |
||||
RESMETIROM, HYDROCHLOROTHIAZIDE, VALSARTAN, VALSARTAN ORAL, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, LABETALOL HYDROCHLORIDE, LABETALOL, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, AMLODIPINE BESYLATE, FAMOTIDINE, VITAMIN E, EZETIMIBE, |
||||
| 442 | 26544696 |
EU |
74 | 2 |
Hepatic encephalopathy, Device related infection, Psoriasis, Pruritus, |
||||
DURVALUMAB, |
||||
| 443 | 26544773 |
|||
Pruritus, Off label use, |
||||
BIMEKIZUMAB, |
||||
| 444 | 26544815 |
52 | ||
Pruritus, Rash erythematous, Skin burning sensation, Product dose omission issue, |
||||
BIMEKIZUMAB, |
||||
| 445 | 26544827 |
30 | 2 | |
Product leakage, Infusion site erythema, Infusion site discolouration, Infusion site swelling, Infusion site pain, Pruritus, Contusion, Fatigue, |
||||
TOPIRAMATE, DUPILUMAB, ALPRAZOLAM, |
||||
| 446 | 26544882 |
41 | ||
Myalgia, Pruritus, |
||||
RESMETIROM, RESMETIROM, ROSUVASTATIN, PANTOPRAZOLE SODIUM, |
||||
| 447 | 26544913 |
AU |
56 | 2 |
Skin warm, Pruritus, Rash, |
||||
ESTRADIOL/NORETHINDRONE ACETATE, |
||||
| 448 | 26545145 |
US |
2 | |
Urticaria, Pruritus, |
||||
OMALIZUMAB, |
||||
| 449 | 26545252 |
US |
3 | 1 |
Diarrhoea, Behaviour disorder due to a general medical condition, Pruritus, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 450 | 26545275 |
US |
49 | 2 |
Product dose omission issue, Contusion, Pruritus, Accidental exposure to product, Device issue, |
||||
OMALIZUMAB, DULOXETINE HYDROCHLORIDE, |
||||
| 451 | 26545709 |
2 | ||
Tension, Musculoskeletal stiffness, Pruritus, Agitation, Drug ineffective, |
||||
FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 452 | 26545753 |
39 | ||
Erythema, Pruritus, Skin burning sensation, |
||||
BIMEKIZUMAB, |
||||
| 453 | 26545812 |
CA |
50 | 2 |
Abdominal pain, Asthenia, Back pain, Blood pressure diastolic abnormal, Blood pressure diastolic increased, Blood pressure increased, Blood pressure systolic abnormal, Blood pressure systolic increased, Cold sweat, Contusion, Dizziness, Drug ineffective, Fatigue, Gait disturbance, Headache, Heart rate decreased, Heart rate increased, Infection, Influenza, Infusion related reaction, Insomnia, Intentional dose omission, Limb discomfort, Lower respiratory tract infection, Musculoskeletal discomfort, Nasal disorder, Nasopharyngitis, Nausea, Neck pain, Oxygen saturation decreased, Pain, Pain in extremity, Paraesthesia, Pruritus, Skin laceration, Spinal osteoarthritis, Spinal pain, Spinal stenosis, Spondylitis, Urticaria, Weight decreased, Weight increased, |
||||
TOCILIZUMAB, TRAMADOL HYDROCHLORIDE, BIOTIN, IRBESARTAN, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHOTREXATE, METHOTREXATE SODIUM, IBUPROFEN, IBUPROFEN AND DIPHENHYDRAMINE CITRATE, PREDNISONE, ACETAMINOPHEN, |
||||
| 454 | 26545899 |
40 | ||
Pruritus, Product dose omission issue, |
||||
BIMEKIZUMAB, |
||||
| 455 | 26546014 |
US |
23 | 2 |
Product use in unapproved indication, Pruritus, Skin haemorrhage, Skin weeping, Skin fissures, Dry skin, Eczema, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 456 | 26546017 |
US |
16 | 2 |
Pruritus, Dermatitis atopic, Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 457 | 26546027 |
US |
73 | 2 |
Product storage error, Pruritus, Dry skin, |
||||
DUPILUMAB, HYDROXYZINE, HYDROXYZINE, |
||||
| 458 | 26546055 |
US |
2 | |
Dry skin, Pruritus, Hair injury, |
||||
KETOCONAZOLE, |
||||
| 459 | 26546057 |
US |
69 | 2 |
Skin plaque, Skin haemorrhage, Pruritus, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, PEMBROLIZUMAB, |
||||
| 460 | 26546058 |
US |
65 | 1 |
Pruritus, Skin exfoliation, Dry skin, |
||||
DUPILUMAB, |
||||
| 461 | 26546060 |
US |
29 | 2 |
Rash erythematous, Pruritus, Skin burning sensation, Condition aggravated, Rash, |
||||
DUPILUMAB, |
||||
| 462 | 26546081 |
US |
64 | 2 |
Pruritus, |
||||
DUPILUMAB, |
||||
| 463 | 26546090 |
US |
66 | 2 |
Urticaria, Rash erythematous, Pruritus, Skin burning sensation, Condition aggravated, Product use in unapproved indication, |
||||
DUPILUMAB, |
||||
| 464 | 26546109 |
46 | 2 | |
Tachypnoea, Hypersensitivity, Pruritus, Urticaria, Chest discomfort, Erythema, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, |
||||
| 465 | 26546384 |
GB |
87 | 1 |
Pruritus, Urticaria, |
||||
DALBAVANCIN HYDROCHLORIDE, DALBAVANCIN, EPLERENONE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, APIXABAN, BUMETANIDE, SENNOSIDES, SENNA LEAF, SENNA, BISOPROLOL FUMARATE, |
||||
| 466 | 26546584 |
US |
2 | |
Renal disorder, Influenza like illness, Malaise, Asthenia, Brain fog, Muscle twitching, Somnolence, Skin burning sensation, Throat irritation, Urticaria, Pain, Back pain, Fatigue, Insomnia, Pruritus, Rash, |
||||
LEVOKETOCONAZOLE, LEVOKETOCONAZOLE, SPIRONOLACTONE, |
||||
| 467 | 26546654 |
|||
Dermo-hypodermitis, Nausea, Dysgeusia, Abdominal pain, Diarrhoea, Biliary colic, Gastrooesophageal reflux disease, Headache, Injection site pain, Arthralgia, Eosinophilia, Lipase increased, Lymphopenia, Fungal infection, Conjunctivitis, Oral herpes, Morphoea, Pruritus, Urticaria, Weight increased, |
||||
ZILUCOPLAN, |
||||
| 468 | 26552383 |
43 | 1 | |
Road traffic accident, Pruritus, Treatment delayed, |
||||
RISANKIZUMAB-RZAA, |
||||
| 469 | 26552387 |
86 | 1 | |
Pruritus, |
||||
LENALIDOMIDE, |
||||
| 470 | 26554649 |
|||
Infusion related reaction, Palpitations, Dyspnoea, Abdominal pain lower, Pruritus, |
||||
FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, FOSAPREPITANT, FOSAPREPITANT DIMEGLUMINE, |
||||
| 471 | 26554716 |
33 | 2 | |
Urticaria, Dyspnoea, Pruritus, |
||||
| 472 | 26558337 |
65 | 2 | |
Tongue discomfort, Neuralgia, Pruritus, Rash, Muscle spasms, |
||||
GADOTERIDOL, |
||||
| 473 | 26535833 |
CN |
62 | 2 |
Pruritus, |
||||
| 474 | 26535844 |
EU |
80 | 2 |
Pemphigoid, Rash vesicular, Pruritus, Pain, |
||||
| 475 | 26535944 |
US |
78 | 2 |
Urticaria, Pruritus, |
||||
AZILSARTAN KAMEDOXOMIL, |
||||
| 476 | 26536003 |
|||
Erythema, Pruritus, Skin burning sensation, Therapy interrupted, |
||||
BIMEKIZUMAB, |
||||
| 477 | 26536079 |
62 | ||
Nasopharyngitis, Pruritus, Urinary tract infection, |
||||
BIMEKIZUMAB, |
||||
| 478 | 26536240 |
US |
38 | 2 |
Emotional disorder, Confusional state, Pruritus, Irritability, |
||||
ZURANOLONE, |
||||
| 479 | 26536243 |
CN |
54 | 2 |
Gastrooesophageal reflux disease, Abdominal pain upper, Pruritus, Muscular weakness, Fatigue, Treatment noncompliance, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), LETROZOLE, LETROZOLE TABLETS, MEGESTROL ACETATE, |
||||
| 480 | 26536244 |
GB |
61 | 2 |
Posterior reversible encephalopathy syndrome, Rash, Pruritus, |
||||
PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), ANASTROZOLE, ANASTROZOLE TABLETS, DENOSUMAB, |
||||
| 481 | 26536252 |
US |
81 | 1 |
Pruritus, |
||||
POMALIDOMIDE, |
||||
| 482 | 26536351 |
EU |
78 | 2 |
Urinary tract infection, Ankle fracture, Mucosal inflammation, Pruritus, Anaemia, |
||||
CARBOPLATIN, DOSTARLIMAB, PACLITAXEL, PACLITAXEL (AIBUMIN-BOUND), |
||||
| 483 | 26536371 |
GB |
29 | 2 |
Amnesia, Agitation, Throat irritation, Eye pruritus, Libido increased, Constipation, Pruritus, |
||||
| 484 | 26536471 |
US |
||
Pruritus, |
||||
TIRZEPATIDE, |
||||
| 485 | 26536886 |
CN |
58 | 2 |
Pruritus, |
||||
ISATUXIMAB, |
||||
| 486 | 26536974 |
54 | ||
Pruritus, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 487 | 26536992 |
US |
45 | 2 |
Pruritus, Loss of therapeutic response, |
||||
TRALOKINUMAB-LDRM, TRALOKINUMAB-LDRM, |
||||
| 488 | 26537076 |
US |
74 | 1 |
Dry skin, Pruritus, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 489 | 26537150 |
US |
||
Erythema, Rash, Pruritus, |
||||
UPADACITINIB, SECUKINUMAB, |
||||
| 490 | 26537189 |
US |
55 | 2 |
Pruritus, Erythema, |
||||
POMALIDOMIDE, |
||||
| 491 | 26537218 |
US |
72 | 1 |
Pruritus, |
||||
POMALIDOMIDE, |
||||
| 492 | 26537219 |
US |
70 | 2 |
Pneumonia, Cellulitis, Skin exfoliation, Skin discolouration, Pruritus, |
||||
ABATACEPT, ABATACEPT, ABATACEPT, FOLIC ACID, HYDROXYCHLOROQUINE, LISINOPRIL, METHOTREXATE, METHOTREXATE SODIUM, PANTOPRAZOLE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 493 | 26537256 |
US |
||
Pain of skin, Pruritus, Device malfunction, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 494 | 26537258 |
US |
||
Neuropathy peripheral, Pruritus, Myalgia, |
||||
| 495 | 26537312 |
US |
47 | 1 |
Hydronephrosis, Renal tubular injury, Angioedema, Lip swelling, Acute kidney injury, Cellulitis, Erythema, Pruritus, Pustule, Pyrexia, Skin exfoliation, Leukocytosis, |
||||
| 496 | 26537389 |
36 | ||
Pruritus, Erythema, Chest discomfort, Needle issue, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 497 | 26537433 |
CA |
2 | |
Crohn^s disease, Pruritus, Liver function test abnormal, |
||||
GUSELKUMAB, GUSELKUMAB, GUSELKUMAB, GUSELKUMAB, |
||||
| 498 | 26537485 |
CA |
43 | 2 |
Intentional product use issue, Irritable bowel syndrome, Joint range of motion decreased, Lower limb fracture, Lower respiratory tract infection, Lupus vulgaris, Malaise, Maternal exposure during pregnancy, Mobility decreased, Muscle injury, Nasopharyngitis, Nausea, Off label use, Prescribed overdose, Prescribed underdose, Pruritus, Sciatica, Sinusitis, Sleep disorder, Therapeutic product effect decreased, Therapeutic response decreased, Type 2 diabetes mellitus, Ulcer haemorrhage, Vomiting, Wheezing, Wound infection, |
||||
NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, RITUXIMAB, |
||||
| 499 | 26537499 |
|||
Pneumonia, Pruritus, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, FOLIC ACID, CALCIUM, |
||||
| 500 | 26537530 |
US |
||
Pruritus, |
||||
IPRATROPIUM BROMIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28